Get the Stockscreener App
261.72
0.06%
-0.16
After Hours:
261.72
Overview
News
Price History
Option Chain
Financials
Why LH Down?
Discussions
Forecast
Stock Split
Dividend History
Labcorp Holdings Inc stock is traded at $261.72, with a volume of 527.44K.
It is down -0.06% in the last 24 hours and up +0.43% over the past month.
Labcorp is one of the nation's two largest independent clinical laboratories, with roughly 20% of the independent lab market. The company operates approximately 2,000 patient-service centers, offering a broad range of 5,000 clinical lab tests, ranging from routine blood and urine screens to complex oncology and genomic testing.
See More
Previous Close:
$261.88
Open:
$261.85
24h Volume:
527.44K
Relative Volume:
0.67
Market Cap:
$21.91B
Revenue:
$12.71B
Net Income/Loss:
$435.50M
P/E Ratio:
50.82
EPS:
5.15
Net Cash Flow:
$843.20M
1W Performance:
+3.83%
1M Performance:
+0.43%
6M Performance:
+6.30%
1Y Performance:
+24.19%
1-Day Range:
$260.16
$263.77
1-Week Range:
$248.56
$283.47
52-Week Range:
$209.38
$283.47
Labcorp Holdings Inc Stock (LH) Company Profile
Name
Labcorp Holdings Inc
Sector
Industry
Phone
(336) 229-1127
Address
358 S MAIN ST, BURLINGTON, NC
Compare LH with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LH
Labcorp Holdings Inc
|
261.72 | 21.71B | 12.71B | 435.50M | 843.20M | 5.15 |
|
TMO
Thermo Fisher Scientific Inc
|
482.16 | 183.07B | 43.21B | 6.58B | 6.17B | 17.29 |
|
DHR
Danaher Corp
|
206.85 | 145.32B | 24.01B | 3.41B | 4.86B | 4.70 |
|
IDXX
Idexx Laboratories Inc
|
573.07 | 45.56B | 3.93B | 894.97M | 837.70M | 10.82 |
|
A
Agilent Technologies Inc
|
119.84 | 33.96B | 6.63B | 1.17B | 1.19B | 4.05 |
|
IQV
Iqvia Holdings Inc
|
194.55 | 33.62B | 15.50B | 1.33B | 2.16B | 7.34 |
Labcorp Holdings Inc Stock (LH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-10-25 | Downgrade | HSBC Securities | Buy → Hold |
| Apr-02-25 | Initiated | Redburn Atlantic | Buy |
| Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
| Jan-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Dec-10-24 | Resumed | Jefferies | Buy |
| Oct-30-24 | Upgrade | HSBC Securities | Hold → Buy |
| Oct-01-24 | Initiated | Piper Sandler | Neutral |
| Mar-25-24 | Upgrade | Argus | Hold → Buy |
| Feb-26-24 | Initiated | Leerink Partners | Outperform |
| Feb-09-24 | Initiated | Evercore ISI | In-line |
| Jan-03-24 | Initiated | Barclays | Equal Weight |
| Sep-06-23 | Initiated | HSBC Securities | Hold |
| Dec-12-22 | Downgrade | Citigroup | Buy → Neutral |
| Sep-19-22 | Downgrade | Argus | Buy → Hold |
| Aug-22-22 | Resumed | Morgan Stanley | Overweight |
| Jan-28-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jan-11-21 | Upgrade | Argus | Hold → Buy |
| Jan-11-21 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| Jan-08-21 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| Jul-14-20 | Upgrade | BofA Securities | Neutral → Buy |
| Jul-13-20 | Upgrade | Wolfe Research | Peer Perform → Outperform |
| Jun-02-20 | Resumed | Deutsche Bank | Buy |
| May-15-20 | Upgrade | Mizuho | Neutral → Buy |
| Apr-29-20 | Downgrade | KeyBanc Capital Markets | Overweight → Sector Weight |
| Apr-27-20 | Upgrade | Citigroup | Neutral → Buy |
| Apr-27-20 | Upgrade | Wolfe Research | Underperform → Peer Perform |
| Jan-08-20 | Initiated | Wells Fargo | Overweight |
| Jul-16-19 | Upgrade | BofA/Merrill | Underperform → Neutral |
| Jun-21-19 | Upgrade | Deutsche Bank | Hold → Buy |
| Apr-02-19 | Upgrade | Jefferies | Hold → Buy |
| Jan-17-19 | Initiated | UBS | Buy |
| Jan-03-19 | Downgrade | BofA/Merrill | Neutral → Underperform |
| Dec-03-18 | Downgrade | Craig Hallum | Buy → Hold |
| Oct-30-18 | Downgrade | Argus | Buy → Hold |
| Oct-25-18 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-19-18 | Resumed | BofA/Merrill | Buy |
| Jun-07-18 | Upgrade | KeyBanc Capital Mkts | Sector Weight → Overweight |
| May-01-18 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-23-18 | Initiated | Argus | Buy |
View All
Labcorp Holdings Inc Stock (LH) Latest News
Why Labcorp Holdings (LH) is a Top Value Stock for the Long-Term - Yahoo Finance
Labcorp Achieves IVDR CE-Marking for PGDx elio™ tissue complete in the EU - PR Newswire
Should I hold or sell Labcorp Holdings Inc. stock in 2025Best Dividend Outlook For Consistent Profits - jammulinksnews.com
What makes Labcorp Holdings Inc. stock price move sharplyAI Trading Suggestions With Accuracy Focus Released - metal.it
Labcorp’s SWOT analysis: diagnostics giant’s stock faces valuation scrutiny By Investing.com - Investing.com Nigeria
Labcorp’s SWOT analysis: diagnostics giant’s stock faces valuation scrutiny - Investing.com Australia
FTRE Investors Have Opportunity to Lead Fortrea Holdings Inc. Securities Fraud Lawsuit with the Schall Law Firm - Benzinga
Pomerantz Law Firm Announces the Filing of a Class Action Against Fortrea Holdings, Inc. and Certain Officers – FTRE - FinancialContent
Is it the right time to buy Labcorp Holdings Inc. stockFree Capital Allocation Plans - jammulinksnews.com
When is Labcorp Holdings Inc. stock expected to show significant growthBest Dividend Report With High Returns - jammulinksnews.com
Gift of Life in Collaboration with Labcorp and DOUBLEMINT®, Launch Hero Gum to Expand Marrow Donor Registry - Yahoo Finance
How strong is Labcorp Holdings Inc. company’s balance sheetHigh-octane financial growth - jammulinksnews.com
Labcorp Holdings Inc. stock outperforms competitors on strong trading day - MSN
What is the risk reward ratio of investing in Labcorp Holdings Inc. stockCapitalize on strong market momentum - jammulinksnews.com
Does Labcorp Holdings Inc. stock perform well during market downturnsCapitalize on fast-growing investment opportunities - jammulinksnews.com
What analysts say about Labcorp Holdings Inc. stock outlookFree Investment Group - metal.it
How does Labcorp Holdings Inc. compare to its industry peersUnlock hidden market opportunities today - jammulinksnews.com
Labcorp raises annual profit forecast on strong diagnostic testing demand - MSN
Labcorp Holdings Second Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
Why Labcorp Holdings Inc. stock attracts strong analyst attentionPotential Rocket List - metal.it
Labcorp: Q2 Earnings Snapshot - Norwalk Hour
What drives Labcorp Holdings Inc. stock priceMarket-beating performance - PrintWeekIndia
Labcorp Holdings (LH) Completes Share Buyback and Reports Strong Q2 Earnings Growth - Yahoo Finance
Labcorp Holdings (LH): Analyst Rating Maintained, Price Target Raised | LH Stock News - GuruFocus
UBS Maintains Buy Rating and Raises Price Target for Labcorp (LH) | LH Stock News - GuruFocus
Positive Outlook for Labcorp Holdings: Buy Rating Justified by Strong Future Prospects and Strategic Growth Initiatives - TipRanks
What analysts say about Labcorp Holdings Inc. stockExponential return rates - PrintWeekIndia
These Analysts Boost Their Forecasts On Labcorp Following Better-Than-Expected Q2 Earnings - Benzinga
Morgan Stanley Raises Price Target for Labcorp (LH) to $306 | LH Stock News - GuruFocus
Labcorp Holdings Inc. (NYSE:LH) Q2 2025 Earnings Call Transcript - Insider Monkey
Labcorp (LH) Price Target Boosted by Morgan Stanley | LH Stock News - GuruFocus
Labcorp price target raised to $306 from $283 at Morgan Stanley - TipRanks
Labcorp Holdings Shows Improved Relative Price Performance; Still Shy Of Benchmark - Investor's Business Daily
What makes Labcorp Holdings Inc. stock attractive to long term investorsRecord-setting profit potential - jammulinksnews.com
Labcorp Holdings Reports Strong Growth and Raises Guidance - TipRanks
Labcorp Holdings stock hits 52-week high at $265.95 By Investing.com - Investing.com Canada
Research Alert: CFRA Maintains Buy Opinion On Labcorp Holdings Inc. - 富途牛牛
Labcorp price target raised to $300 from $290 at Jefferies - TipRanks
Laboratory Corporation of America stock price target raised to $323 at Leerink - Investing.com
Labcorp (LH) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates - Yahoo Finance
Labcorp price target raised to $300 from $285 at Evercore ISI - TipRanks
Labcorp (LH) Shares Skyrocket, What You Need To Know - Yahoo Finance
Why Is Testing Giant Labcorp Stock Surging On Thursday? - Benzinga
Labcorp Q2 Earnings & Revenues Beat Estimates, Stock Up in Pre-Market - The Globe and Mail
Labcorp (LH) Q2 2025 Earnings Call Transcript - Mitrade
Earnings call transcript: Labcorp Q2 2025 sees strong EPS, revenue growth - Investing.com Nigeria
Labcorp Holdings Inc Stock (LH) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.05%
1.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):